Tag Archives: Phase 2 PreSERVE AMI clinical trial (NBS

Neostem Trial Reinforces CR Way Stem Cell Replacement Strategy!

Hurray for Neostem! The results of its clinical trial were released yesterday, and they are positive (from a CR Way perspective). Here is Robin Smith, the CEO of Neostem, explaining the results. http://www.bloomberg.com/video/neostem-ceo-clincial-heart-trials-show-stem-cell-success-FcXS4rt~T8C0I7wSAm2LDw.html Here is the press release: 5:16 pm Neostem announces initial ‘positive’ data from Phase 2 PreSERVE AMI clinical trial : Co announced… read more